{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:39:11Z","timestamp":1793612351501,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI22C0471 and HI22C1723"],"award-info":[{"award-number":["HI22C0471 and HI22C1723"]}]},{"name":"Ministry of Science, Information and Communication Technologies & Future Planning, Republic of Korea","award":["RS-2023-00305153"],"award-info":[{"award-number":["RS-2023-00305153"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13985-5","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T02:14:00Z","timestamp":1743214440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors that predict progression of von Hippel-Lindau disease-related malignancy: a longitudinal cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jae Ho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Wook","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangjoon","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moinay","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryn","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"5112","key":"13985_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260(5112):1317\u201320.","journal-title":"Science"},{"issue":"5","key":"13985_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82(5):529\u201342.","journal-title":"Eur Urol"},{"issue":"6","key":"13985_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A","volume":"13","author":"C Gallou","year":"1999","unstructured":"Gallou C, Joly D, Mejean A, Staroz F, Martin N, Tarlet G, et al. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum Mutat. 1999;13(6):464\u201375.","journal-title":"Hum Mutat"},{"issue":"1","key":"13985_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/MPA.0b013e31815f394a","volume":"37","author":"O Corcos","year":"2008","unstructured":"Corcos O, Couvelard A, Giraud S, Vullierme MP, O\u2019Toole D, Rebours V, et al. Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features. Pancreas. 2008;37(1):85\u201393.","journal-title":"Pancreas"},{"issue":"8","key":"13985_CR5","doi-asserted-by":"publisher","first-page":"104538","DOI":"10.1016\/j.ejmg.2022.104538","volume":"65","author":"MBM Louise","year":"2022","unstructured":"Louise MBM, Smerdel M, Borgwadt L, Beck Nielsen SS, Madsen MG, Moller HU, et al. von Hippel-Lindau disease: updated guideline for diagnosis and surveillance. Eur J Med Genet. 2022;65(8):104538.","journal-title":"Eur J Med Genet"},{"issue":"3","key":"13985_CR6","doi-asserted-by":"publisher","first-page":"675.e1","DOI":"10.1016\/j.urology.2013.09.069","volume":"83","author":"X Wang","year":"2014","unstructured":"Wang X, Zhang N, Ning X, Li T, Wu P, Peng S, et al. Higher prevalence of novel mutations in VHL gene in Chinese Von Hippel-Lindau disease patients. Urology. 2014;83(3):675.e1-5.","journal-title":"Urology"},{"issue":"5","key":"13985_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/jmedgenet-2017-104995","volume":"55","author":"JY Wang","year":"2018","unstructured":"Wang JY, Peng SH, Li T, Ning XH, Liu SJ, Hong BA, et al. Risk factors for survival in patients with von Hippel-Lindau disease. J Med Genet. 2018;55(5):322\u20138.","journal-title":"J Med Genet"},{"issue":"24","key":"13985_CR8","doi-asserted-by":"publisher","first-page":"38456","DOI":"10.18632\/oncotarget.16594","volume":"8","author":"S Peng","year":"2017","unstructured":"Peng S, Shepard MJ, Wang J, Li T, Ning X, Cai L, et al. Genotype-phenotype correlations in Chinese von Hippel-Lindau disease patients. Oncotarget. 2017;8(24):38456\u201365.","journal-title":"Oncotarget"},{"issue":"5","key":"13985_CR9","first-page":"521","volume":"31","author":"M Nordstrom-O'Brien","year":"2010","unstructured":"Nordstrom-O\u2019Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, et al. Genetic analysis of von Hippel-Lindau disease. Hum Mutat. 2010;31(5):521\u201337.","journal-title":"Hum Mutat"},{"issue":"1","key":"13985_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1001\/jamaoncol.2017.3428","volume":"4","author":"A Tirosh","year":"2018","unstructured":"Tirosh A, Sadowski SM, Linehan WM, Libutti SK, Patel D, Nilubol N, et al. Association of VHL genotype with pancreatic neuroendocrine tumor phenotype in patients with von Hippel-Lindau Disease. JAMA Oncol. 2018;4(1):124\u20136.","journal-title":"JAMA Oncol"},{"issue":"2","key":"13985_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer."},{"issue":"10","key":"13985_CR12","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/ajmg.a.33023","volume":"149A","author":"A McNeill","year":"2009","unstructured":"McNeill A, Rattenberry E, Barber R, Killick P, MacDonald F, Maher ER. Genotype-phenotype correlations in VHL exon deletions. Am J Med Genet A. 2009;149A(10):2147\u201351.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"13985_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00268-021-06393-w","volume":"46","author":"M Dhanda","year":"2022","unstructured":"Dhanda M, Agarwal A, Mandal K, Gupta S, Sabaretnam M, Chand G, et al. Clinical, biochemical, tumoural and mutation profile of VHL- and MEN2A-associated pheochromocytoma: a comparative study. World J Surg. 2022;46(3):591\u20139.","journal-title":"World J Surg"},{"issue":"10","key":"13985_CR14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/gim.2017.261","volume":"20","author":"SJ Liu","year":"2018","unstructured":"Liu SJ, Wang JY, Peng SH, Li T, Ning XH, Hong BA, et al. Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-alpha binding site in VHL protein. Genet Med. 2018;20(10):1266\u201373.","journal-title":"Genet Med"},{"issue":"1","key":"13985_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/gim.2015.44","volume":"18","author":"ML Binderup","year":"2016","unstructured":"Binderup ML, Budtz-J\u00f8rgensen E, Bisgaard ML. Risk of new tumors in von Hippel-Lindau patients depends on age and genotype. Genet Med. 2016;18(1):89\u201397.","journal-title":"Genet Med"},{"issue":"2","key":"13985_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/humu.20385","volume":"28","author":"KR Ong","year":"2007","unstructured":"Ong KR, Woodward ER, Killick P, Lim C, Macdonald F, Maher ER. Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat. 2007;28(2):143\u20139.","journal-title":"Hum Mutat"},{"key":"13985_CR17","doi-asserted-by":"publisher","first-page":"570103","DOI":"10.3389\/fonc.2020.570103","volume":"10","author":"X Yin","year":"2020","unstructured":"Yin X, Duan H, Yi Z, Li C, Lu R, Li L. Incidence, prognostic factors and survival for hemangioblastoma of the central nervous system: analysis based on the surveillance, epidemiology, and end results database. Front Oncol. 2020;10:570103.","journal-title":"Front Oncol"},{"key":"13985_CR18","doi-asserted-by":"publisher","first-page":"106281","DOI":"10.1016\/j.clineuro.2020.106281","volume":"199","author":"Q Wang","year":"2020","unstructured":"Wang Q, Meng S, Cheng J, Zhang S, Ju Y, Fang Y, et al. Central nervous system hemangioblastomas: an age-stratified analysis. Clin Neurol Neurosurg. 2020;199:106281.","journal-title":"Clin Neurol Neurosurg"},{"key":"13985_CR19","doi-asserted-by":"crossref","unstructured":"Mazzapicchi E, Restelli F, Falco J, Broggi M, Gatti L, Alongi P, et al. Sporadic and von Hippel-Lindau related hemangioblastomas of brain and spinal cord: multimodal imaging for intraoperative strategy. Cancers (Basel). 2022;14(22).","DOI":"10.3390\/cancers14225492"},{"key":"13985_CR20","doi-asserted-by":"crossref","unstructured":"Peyre M, David P, Van Effenterre R, Fran\u00e7ois P, Thys M, Emery E, et al. Natural history of supratentorial hemangioblastomas in von Hippel-Lindau disease. Neurosurgery. 2010;67(3):577\u201387; discussion 587.","DOI":"10.1227\/01.NEU.0000374846.86409.A7"},{"key":"13985_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-3-7091-6912-4_6","volume":"20","author":"F Resche","year":"1993","unstructured":"Resche F, Moisan JP, Mantoura J, de Kersaint-Gilly A, Andre MJ, Perrin-Resche I, et al. Haemangioblastoma, haemangioblastomatosis, and von Hippel-Lindau disease. Adv Tech Stand Neurosurg. 1993;20:197\u2013304.","journal-title":"Adv Tech Stand Neurosurg"},{"issue":"1","key":"13985_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3171\/jns.2003.98.1.0082","volume":"98","author":"JE Wanebo","year":"2003","unstructured":"Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98(1):82\u201394.","journal-title":"J Neurosurg"},{"issue":"6","key":"13985_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/jmedgenet-2018-105567","volume":"56","author":"X Peng","year":"2019","unstructured":"Peng X, Chen J, Wang J, Peng S, Liu S, Ma K, et al. Natural history of renal tumours in von Hippel-Lindau disease: a large retrospective study of Chinese patients. J Med Genet. 2019;56(6):380\u20137.","journal-title":"J Med Genet"},{"issue":"7","key":"13985_CR24","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/ijc.34793","volume":"154","author":"M Majdoub","year":"2024","unstructured":"Majdoub M, Yanagisawa T, Quhal F, Laukhtina E, von Deimling M, Kawada T, et al. Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysis. Int J Cancer. 2024;154(7):1309\u201323.","journal-title":"Int J Cancer"},{"issue":"3","key":"13985_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14740\/wjon1279","volume":"11","author":"SA Padala","year":"2020","unstructured":"Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79\u201387.","journal-title":"World J Oncol"},{"issue":"4","key":"13985_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/KCA-190068","volume":"3","author":"SdC Zequi","year":"2019","unstructured":"Zequi SdC, Mour\u00e3o TC, de Oliveira MM, Curado MP, Gueglio G, da Costa WH, et al. Predictors of survival outcomes in non-metastatic renal cell carcinoma in Latin America and Spain: a multicentric analysis. Kidney Cancer. 2019;3(4):253\u201361.","journal-title":"Kidney Cancer"},{"issue":"4","key":"13985_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.euf.2017.01.006","volume":"4","author":"G Scelo","year":"2018","unstructured":"Scelo G, Li P, Chanudet E, Muller DC. Variability of sex disparities in cancer incidence over 30 years: the striking case of kidney cancer. Eur Urol Focus. 2018;4(4):586\u201390.","journal-title":"Eur Urol Focus"},{"issue":"6","key":"13985_CR28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/003655902762467558","volume":"36","author":"C Beisland","year":"2002","unstructured":"Beisland C, Medby PC, Beisland HO. Renal cell carcinoma: gender difference in incidental detection and cancer-specific survival. Scand J Urol Nephrol. 2002;36(6):414\u20138.","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"13985_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.eururo.2007.12.001","volume":"54","author":"M Aron","year":"2008","unstructured":"Aron M, Nguyen MM, Stein RJ, Gill IS. Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol. 2008;54(1):133\u201340.","journal-title":"Eur Urol"},{"issue":"5","key":"13985_CR30","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.juro.2008.01.024","volume":"179","author":"JM Woldrich","year":"2008","unstructured":"Woldrich JM, Mallin K, Ritchey J, Carroll PR, Kane CJ. Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993\u20132004. J Urol. 2008;179(5):1709\u201313 discussion 13.","journal-title":"J Urol."},{"key":"13985_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2407-5-57","volume":"5","author":"KP van Houwelingen","year":"2005","unstructured":"van Houwelingen KP, van Dijk BA, Hulsbergen-van de Kaa CA, Schouten LJ, Gorissen HJ, Schalken JA, et al. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study. BMC Cancer. 2005;5:57.","journal-title":"BMC Cancer."},{"issue":"10","key":"13985_CR32","doi-asserted-by":"publisher","first-page":"e0311665","DOI":"10.1371\/journal.pone.0311665","volume":"19","author":"S Hwang","year":"2024","unstructured":"Hwang S, Kang SW, Kim JW, Kim SJ. Genotype-phenotype correlation of ocular von Hippel-Lindau disease in Koreans. PLoS ONE. 2024;19(10): e0311665.","journal-title":"PLoS ONE"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13985-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13985-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13985-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:14:38Z","timestamp":1743264878000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13985-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13985"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13985-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Asan Medical Center Institutional Review Board (IRB number: 2020\u20131240) which waived the requirement for informed consent because the patient images were collected retrospectively, and identification information was removed for Health Insurance Portability and Accountability Act (HIPAA) compliance.\u00a0This study was conducted in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"562"}}